Inactive

The Medical Readiness Contracting Office - Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Cerus Corporation for the purchase of Intercept platelet p... The Medical Readiness Contracting Office - Pacific, in support of Tripler Army Medical Center, Hawaii, intends to make a sole source award to Cerus Corporation for the purchase of Intercept platelet pathogen reduction sets for use on the government-owned Cerus Illuminator. This will be for a 12-month base period plus four 12-month options from 1 October 2025 through 30 September 2030. The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(l)(ii) which authorizes the government to award contracts when there is only one responsible source, and no other suppliers or services will satisfy agency requirements. The NAICS code is 325413. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes; however, any capability statement or quotation received will be considered. All questions and responses concerning this notice shall be emailed to lara.a.staley.civ@health.mil. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.

Inactive

This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and capabili... This is a Sources Sought Notice. This is NOT a solicitation for proposals, proposal abstracts or quotations. The purpose of this notice is to obtain information regarding the availability and capability of qualified sources and whether or not to conduct this procurement on a competitive basis. The NAICS code is 325413 and the size standard is 1250. Your response to the information requested will assist the Government in determining the appropriate acquisition method. The Government intends to award a Firm Fixed-Price purchase order to the successful quoter. Tripler Army Medical Center (TAMC) has a requirement for Cerus Intercept Platelet Pathogen Reduction Sets. The platelet pathogen reduction sets are used in conjunction with platelets and plasma in an Intercept processing set. The INTERCEPT Blood System uses amotosalen, a well-characterized photoactive compound that targets DNA and RNA, followed by UVA illumination which irreversibly cross-links nucleic acids. In doing so, the INTERCEPT treatment blocks replication of bacteria, viruses and parasites, rendering them inactive Disclaimer and Important Notes: This does not obligate the Government to award a contract or otherwise pay for the information provided in a response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential or sensitive information should be included in your response.